Navigation Links
LayerBio, Inc. Announces Launch; Signs Option for Technology from MIT
Date:11/13/2013

Cambridge, MA (PRWEB) November 13, 2013

President and CEO, Dr. Kenneth Mandell, announces the formation of LayerBio, Inc. and inks an exclusive option for a unique technology from Massachusetts Institute of Technology (MIT). Under this agreement, LayerBio will commercialize a drug delivery platform developed in the laboratory of Co-Founder Dr. Paula Hammond, David H. Koch Professor in Engineering and leading expert in biomaterials and drug delivery. Dr. Hammond maintains her faculty position at MIT and joins LayerBio as Chair of the Scientific Advisory Board.

“Securing an option agreement with MIT marks a significant event in the formation of LayerBio. Dr. Hammond represents the highest caliber of scientific expertise and the technology offers multiple opportunities for improved drug delivery in the fields of ophthalmology, wound care and other therapeutic areas,” commented Dr. Mandell.

LayerBio’s platform, LayerForm™, is a conformal, tunable and bioerodible polymer technology that enables coating and release of drugs from various medical devices. It is compatible with small molecules, nucleic acids and biologic drugs and has been tested on a variety of substrates, including bandages, sutures, ophthalmic lenses and other topical and implantable devices. There are numerous potential applications for LayerBio’s distinctive technology.

LayerBio will initially focus on applications in ophthalmology and wound care. These markets are rapidly-growing with significant unmet needs for effective drug delivery. “By targeting therapies in controlled fashion to the site of action, including drugs that are typically more challenging to deliver such as siRNA and biologics, our technology can improve safety, efficacy and convenience for patients,” said Dr. Hammond.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11319365.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER FINANCIAL RESULTS
2. iLab Solutions Announces Jessica Evans as the Project Manager for their European Business Expansion
3. TrueVision Announces TrueGuide™ Computer-Guided Surgery System for Cataract Surgery
4. Eli Sapharti Announces His Success Story “From Fat Boy To Fit Man”
5. Cellular Biomedicine Group Announces Adjournment of Its Annual Shareholder Meeting
6. DURECT Announces Pricing of Public Offering of Common Stock
7. CTI Announces Data Presentations at the 55th American Society of Hematology Annual Meeting
8. Ambit Biosciences Announces Third Quarter 2013 Operating Results
9. Spherix Announces the Closing of Private Placement of $2,235,000
10. Intelligent Implant Systems Announces 510(k) Clearance of the Marauder Cervical-Thoracic Spinal System
11. karmadata Announces Launch Of App Gallery And The Indicate Investigators App
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network for ... Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is to ... are designed, built and brought to market. , The Design Lab is Supplyframe’s ...
(Date:6/23/2016)... BEACH, Calif. , June 23, 2016  Blueprint ... new biological discoveries to the medical community, has closed ... co-founder Matthew Nunez . "We have ... us with the capital we need to meet our ... will essentially provide us the runway to complete validation ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):